
Osteogenesis imperfecta and therapeutics
Keywords: OI; osteogenesis imperfecta; Brtl; Brittle IV mouse; hMSCs; human mesenchymal stem cells; aBMD; areal bone mineral density; PEDF; pigment epithelium-derived factor; BRIL; bone restricted ifitm-like protein; ER; endoplasmic reticulum; ECM; extra-cellular m